关注
Dr. Saikat Chowdhury
Dr. Saikat Chowdhury
Postdoctoral Scholar, MD ANDERSON CANCER CENTER, HOUSTON, USA
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Comparison of human cell signaling pathway databases—evolution, drawbacks and challenges
S Chowdhury, RR Sarkar
Database 2015, 2015
1302015
Comprehensive Clinical and Molecular Characterization of KRASG12C-Mutant Colorectal Cancer
JT Henry, O Coker, S Chowdhury, JP Shen, VK Morris, A Dasari, ...
JCO Precision Oncology 5, 613-621, 2021
542021
Survival improvement for patients with metastatic colorectal cancer over twenty years
FA Zeineddine, MA Zeineddine, A Yousef, Y Gu, S Chowdhury, A Dasari, ...
NPJ Precision Oncology 7 (1), 16, 2023
452023
Structural and Logical Analysis of a Comprehensive Hedgehog Signaling Pathway to Identify Alternative Drug Targets for Glioma, Colon and Pancreatic Cancer
S Chowdhury, RN Pradhan, RR Sarkar
PLOS ONE 8 (7), e69132, 2013
282013
Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer
S Chowdhury, M Hofree, K Lin, D Maru, S Kopetz, JP Shen
Cancers 13 (19), 4923, 2021
242021
Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach
P Ganguli, S Chowdhury, S Chowdhury, RR Sarkar
Eurasip Journal on Bioinformatics and Systems Biology 2015, 1-19, 2015
162015
Oncogene addiction to GNAS in GNASR201 mutant tumors
A More, I Ito, V Haridas, S Chowdhury, Y Gu, P Dickson, N Fowlkes, ...
Oncogene 41 (35), 4159-4168, 2022
112022
Molecular basis of drug resistance in smoothened receptor: An in silico study of protein resistivity and specificity
N Sinha, S Chowdhury, RR Sarkar
Proteins: Structure, Function, and Bioinformatics 88 (3), 514-526, 2020
92020
Deciphering structural stability and binding mechanisms of potential antagonists with smoothened protein
N Sinha, S Chowdhury, RR Sarkar
Journal of Biomolecular Structure and Dynamics 36 (11), 2917-2937, 2018
82018
Drug targets and biomarker identification from computational study of human notch signaling pathway
S Chowdhury, R Sarkar
Clin. Exp. Pharmacol 3 (137), 2161-1459.1000137, 2013
82013
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma
A Yousef, M Yousef, S Chowdhury, K Abdilleh, M Knafl, P Edelkamp, ...
NPJ Precision Oncology 8 (1), 27, 2024
72024
exploring Notch pathway to elucidate phenotypic plasticity and Intra-tumor Heterogeneity in Gliomas
S Chowdhury, RR Sarkar
Scientific reports 9 (1), 9488, 2019
72019
Temporal protein expression pattern in intracellular signalling cascade during T-cell activation: A computational study
P Ganguli, S Chowdhury, R Bhowmick, RR Sarkar
Journal of biosciences 40, 769-789, 2015
52015
BIOPYDB: a dynamic human cell specific biochemical pathway database with advanced computational analyses platform
S Chowdhury, N Sinha, P Ganguli, R Bhowmick, V Singh, S Nandi, ...
Journal of Integrative Bioinformatics 15 (3), 20170072, 2018
32018
Structural Insight of NICD-MAML Interactions: Virtual Screening, Docking and Molecular Dynamics Study for Identification of Potential Inhibitor
N Sinha, S Chowdhury, RR Sarkar
Letters in Drug Design & Discovery 13 (4), 301-313, 2016
32016
Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma
A Yousef, M Yousef, MA Zeineddine, A More, M Fanaeian, S Chowdhury, ...
JAMA Network Open 7 (2), e240260-e240260, 2024
22024
Intraperitoneal paclitaxel is a safe and effective therapeutic strategy for treating mucinous appendiceal adenocarcinoma
I Ito, AMG Yousef, S Chowdhury, PN Dickson, ZA Naini, MG White, ...
Cancer Research 83 (19), 3184-3191, 2023
22023
Identification of minimal combinations of oncoproteins in notch pathway to suppress human glioblastoma
RR Sarkar, S Chowdhury
US Patent App. 14/527,628, 2016
22016
Defining the KRAS-and ERK-dependent transcriptome in KRAS-mutant cancers
JA Klomp, JE Klomp, CA Stalnecker, KL Bryant, AC Edwards, ...
Science 384 (6700), eadk0775, 2024
12024
631P Using the unique somatic mutation profile of POLE loss of proof-reading mutation helps in selection of patients who may benefit from immunotherapy
G Maddalena, FA Zeineddine, S Chowdhury, M Zeineddine, A Yousef, ...
Annals of Oncology 34, S448-S449, 2023
12023
系统目前无法执行此操作,请稍后再试。
文章 1–20